FGF2 and medulloblastoma: Conversely, exogenous administration of FGF2 induced cytostatic or cytotoxic effects in breast cancer (Wang et al., 1998), Ewing's sarcoma family tumor (Williamson et al., 2004), and medulloblastoma (Fogarty et al., 2007) cell models among others.